Ledger.Open graph →
SEC Form D · filed August 17, 2018

Magnolia Neurosciences Corp

Offering
$13.1M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Roger Mills · Geneva, V8ExecTimothy Dyer · Geneva, V8DirectorAdele Gorrilla · Philadelphia, PAExecBarbara J. Dalton · New York, NYDirectorBenjamin I. Samaroo · Vancouver, British Columbia, CanadaDirectorVincent Lawton · Geneva, V8DirectorJosephine B. Andonissamy · Luxembourg, LuxembourgDirectorIsaac Manke · New York, NYExecAri Qayumi · Menlo Park, CAExecJon D. Hammes · Milwaukee, WIDirectorAlfred Vericel · Paris, I0DirectorJoel J. Marcus · Seattle, WADirectorSheona I. Docksteader · Vancouver, British Columbia, CanadaDirectorJean-Philippe Rocher · Geneva, V8DirectorSteven I. Krause · Vancouver, British Columbia, CanadaExecDean I. Sutton · Vancouver, British Columbia, CanadaExec · DirectorMikhail Kalinichev · Geneva, V8Exec · DirectorTodd W. Kibler · Milwaukee, WIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗